Rapid response of Kasabach-Meritt phenomenon to a combination of oral prednisolone and sirolimus

Indian J Dermatol Venereol Leprol. 2019 May-Jun;85(3):348. doi: 10.4103/ijdvl.IJDVL_453_17.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Oral
  • Anti-Inflammatory Agents / administration & dosage*
  • Drug Therapy, Combination
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Infant
  • Kasabach-Merritt Syndrome / diagnostic imaging*
  • Kasabach-Merritt Syndrome / drug therapy*
  • Male
  • Prednisolone / administration & dosage*
  • Sirolimus / administration & dosage*
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Immunosuppressive Agents
  • Prednisolone
  • Sirolimus